When does the Phesgo patent expire?
I don’t have enough information in the provided materials to determine the Phesgo (pertuzumab + trastuzumab) patent expiration date(s) for your country or the specific patent(s) that control exclusivity. Patent timelines depend on jurisdiction and on which protection applies (for example, composition-of-matter, formulation, use, or pediatric/marketing exclusivity extensions).
What determines Phesgo’s exclusivity end date (patents vs. market exclusivity)?
Even if a patent term ends, market exclusivity can still keep competitors off the market in some regions. The controlling date may be set by:
- Patent term(s) for the underlying biologics and/or combination product
- Regulatory exclusivity periods (which can differ from patent term)
- Any pediatric extensions or other statutory add-ons
- Product-specific litigation outcomes that affect launch timing
Which patents control Phesgo—drug substance, combination, or the subcutaneous product?
Phesgo’s protection can come from multiple layers, such as:
- Patents covering pertuzumab and trastuzumab (the biologic ingredients)
- Patents covering the combination regimen
- Patents covering the subcutaneous formulation/device and dosing method (for the injection)
Those different layers can expire in different years, so the “real” barrier to biosimilar/alternative competition depends on which specific claims remain valid.
Does the patent-expiration answer differ by country (US vs. EU vs. UK)?
Yes. Patent term length, patent filing dates, and regulatory exclusivity rules vary by jurisdiction. You’ll also see different controlling dates in:
- United States (including Orange Book-linked exclusivity concepts and patent listings)
- European Union/UK (often driven by EMA rules and national enforcement)
- Other markets (Canada, Japan, etc.)
If a Phesgo patent expires, can biosimilars launch immediately?
Not necessarily. Launch timing can still be delayed by:
- Remaining valid patents covering other claims
- Regulatory requirements (biosimilar approval and interchangeability)
- Court rulings from patent litigation (where applicable)
- Exclusivity blocks that extend beyond the first patent expiry
What I need to give you the exact expiration date(s)
Reply with:
1) Your country/region (e.g., US, EU, UK, Canada)
2) Whether you mean patent expiration or market exclusivity end date
3) If you want the earliest date, the last date, or all controlling dates
4) Any patent/application number you already have (if you have it)
Then I can map the relevant protection to the likely exclusivity endpoint for Phesgo in that jurisdiction.
---
If you tell me the jurisdiction (for example, “US” or “EU”), I’ll narrow this to the specific expiration/exclusivity dates.